NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-015-2019-0-SG-10 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE SG National Stage 11202104401R Issued
NEI E-015-2019-0-CN-04 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CN National Stage 201980076370.4 Issued
NCI E-065-2017-0-US-06 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US National Stage 16/614,652 11389480 Issued PDF
NEI E-015-2019-0-PCT-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE PCT PCT COMB PCT/US2019/062016 Expired
NCI E-257-2014-0-US-04 IMMUNOGENIC MODULATION BY ENDOCRINE DEPRIVATION THERAPY IMPROVES SENSITIVITY OF TUMOR CELLS TO IMMUNE MEDIATED LYSIS US DIV 16/686,390 Abandoned
NEI E-015-2019-0-EP-06 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE EP National Stage 19832222.4 Pending
NEI E-015-2019-0-JP-08 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP National Stage 2021-527104 Pending
NEI E-015-2019-0-JP-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP DIV 2024-168122 Pending
NCATS E-128-2019-0-US-01 SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME US 62/936,823 Abandoned
NCI E-023-2019-0-US-01 INHIBITORS OF HISTONE DEMETHYLASES US 62/936,722 Abandoned
NEI E-015-2019-0-CA-03 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CA National Stage 3119041 Pending
NEI E-015-2019-0-KR-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE KR National Stage 10-2021-7018798 Pending
NEI E-015-2019-0-IL-07 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE IL National Stage 282791 Pending
NEI E-015-2019-0-AU-02 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE AU National Stage 2019385332 Pending
NCATS E-129-2019-0-US-01 Biofabrication Of Skin Tissues With Dermis And Epidermis In Multiwell Plate Format US 62/936,399 Abandoned
NCI E-106-2017-0-US-03 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US National Stage 16/613,971 11390683 Issued PDF
NCI E-040-2012-0-US-44 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,978 10837019 Issued PDF
NCI E-040-2012-0-US-45 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,994 10829769 Issued PDF
NCI E-040-2012-0-US-43 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US DIV 16/684,962 10829768 Issued PDF
NCI E-179-2019-0-US-01 PEGYLATED RECOMBINANT IMMUNOTOXINS US 62/935,822 Abandoned
NCI E-494-2013-0-DE-32 Methods of Preparing Anti-human Papillomavirus Antigen T Cells DE EP 19209253.4 Issued
NCI E-494-2013-0-FR-31 Methods of Preparing Anti-human Papillomavirus Antigen T Cells FR EP 19209253.4 Issued
NCI E-494-2013-0-NL-34 Methods of Preparing Anti-human Papillomavirus Antigen T Cells NL EP 19209253.4 Issued
NCI E-494-2013-0-EP-10 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP DIV 19209253.4 Issued
NCI E-494-2013-0-IT-33 Methods of Preparing Anti-human Papillomavirus Antigen T Cells IT EP 19209253.4 Issued
NCI E-494-2013-0-ES-35 Methods of Preparing Anti-human Papillomavirus Antigen T Cells ES EP 19209253.4 Issued
NCI E-494-2013-0-GB-36 Methods of Preparing Anti-human Papillomavirus Antigen T Cells GB EP 19209253.4 Issued
NIAID E-120-2001-1-US-01 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 16/684,103 11318196 Expired PDF
NCI E-040-2012-0-US-40 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,524 10900042 Issued PDF
NCI E-040-2012-0-US-41 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,543 10876123 Issued PDF
NCI E-040-2012-0-US-38 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,477 10844387 Issued PDF
NCI E-040-2012-0-US-39 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,494 10829767 Issued PDF
NCI E-040-2012-0-US-42 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,625 10815488 Issued PDF
NCI E-040-2012-0-US-35 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,417 10815487 Issued PDF
NCI E-040-2012-0-US-37 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,453 10738313 Issued PDF
NCI E-040-2012-0-US-36 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,435 10738312 Issued PDF
CC E-158-2017-0-US-03 SYSTEMS, METHOD AND DEVICES FOR ASSISTING OR PERFORMING GUIDING INTERVENTIONAL PROCEDURES USING INERTIAL MEASUREMENT UNITS AND MAGNETOMETER SENSORS US National Stage 16/613,591 Pending
NCI E-175-2016-0-HK-13 ANTI-KRAS-G12D T CELL RECEPTORS HK CN 19132196.7 Pending
NCI E-017-2017-0-US-10 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US National Stage 16/613,187 11980640 Issued PDF
NIBIB E-150-2016-1-US-06 Evans Blue Attachment Enhances Somatostatin Receptor Imaging And Radiotherapy US National Stage 16/613,196 10981866 Issued PDF
NCI E-007-2019-0-PCT-02 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER PCT PCT PCT/US2019/061251 Expired
NCI E-017-2017-0-JP-07 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES JP National Stage 2019-563082 Pending
NCI E-033-2020-0-US-01 Altering The Humoral Immune Hierarchy US 62/935,016 Abandoned
NCI E-035-2017-0-CN-07 STAT3 INHIBITOR FORMULATION CN National Stage 201880031431.0 Abandoned
NCI E-085-2013-0-EP-12 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood EP DIV 19208596.7 Pending
NCI E-127-2017-0-US-07 COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+
MALIGNANCIES 		US National Stage 16/612,495 11440963 Issued PDF
NCI E-099-2014-0-JP-10 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2019-203937 Pending
NCI E-017-2017-0-SG-09 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES SG National Stage 11201910499V Pending
NCI E-127-2017-0-AU-03 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies AU National Stage 2018266103 Issued
NCI E-127-2017-0-JP-06 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies JP National Stage 2019-561944 Issued